Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Clovis Oncology Inc (CLVS)

Clovis Oncology Inc (CLVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 510,277
  • Shares Outstanding, K 104,565
  • Annual Sales, $ 164,520 K
  • Annual Income, $ -369,210 K
  • 60-Month Beta 1.66
  • Price/Sales 3.03
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLVS with:

Options Overview

Details
  • Implied Volatility 81.72%
  • Historical Volatility 33.10%
  • IV Percentile 17%
  • IV Rank 12.44%
  • IV High 258.45% on 09/10/20
  • IV Low 56.61% on 05/14/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 2,863
  • Volume Avg (30-Day) 9,393
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 134,159
  • Open Int (30-Day) 155,149

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.57
  • Number of Estimates 5
  • High Estimate -0.52
  • Low Estimate -0.62
  • Prior Year -1.11
  • Growth Rate Est. (year over year) +48.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.65 +9.46%
on 07/27/21
6.22 -18.17%
on 06/29/21
-1.08 (-17.50%)
since 06/28/21
3-Month
4.65 +9.46%
on 07/27/21
7.24 -29.70%
on 06/09/21
-1.06 (-17.24%)
since 04/28/21
52-Week
4.08 +24.75%
on 11/10/20
11.10 -54.14%
on 02/08/21
-1.06 (-17.24%)
since 07/28/20

Most Recent Stories

More News
Clovis Oncology to Announce Second Quarter 2021 Financial Results and Host Webcast Conference Call on August 4

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2021 financial results on Wednesday, August 4, 2021, before the open of the US financial markets. Clovis' senior management will host...

CLVS : 5.09 (+4.30%)
Thinking about buying stock in Cinedigm, VEON, Alcoa, Clovis Oncology, or Skillz?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CIDM, VEON, AA, CLVS, and SKLZ.

CIDM : 1.6100 (+7.33%)
CLVS : 5.09 (+4.30%)
VEON : 1.7300 (+2.98%)
AA : 38.23 (-0.10%)
SKLZ : 14.68 (+2.95%)
Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, CLVS, XELA, WIT, and ATOS.

ATOS : 3.95 (+0.77%)
XELA : 2.58 (-1.53%)
CLVS : 5.09 (+4.30%)
AHT : 16.55 (-3.10%)
WIT : 8.44 (+1.08%)
Thinking about buying stock in Nokia, Clovis Oncology, Avinger, Ericsson, or New Oriental Education?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, CLVS, AVGR, ERIC, and EDU.

AVGR : 0.9500 (+1.05%)
CLVS : 5.09 (+4.30%)
ERIC : 11.51 (+0.52%)
EDU : 2.36 (+7.76%)
NOK : 5.81 (+1.04%)
Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors

Clovis Oncology, Inc. (NASDAQ: CLVS) announced today the appointment of Dr. Ronit Simantov to its Board of Directors, effective today.

CLVS : 5.09 (+4.30%)
Thinking about buying stock in Toughbuilt Industries, MER Telemanagement Solutions, United Airlines, AST SpaceMobile, or Clovis Oncology?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TBLT, MTSL, UAL, ASTS, and CLVS.

MTSL : 3.37 (-0.88%)
ASTS : 10.87 (-2.07%)
CLVS : 5.09 (+4.30%)
TBLT : 0.6159 (-1.49%)
UAL : 49.14 (+1.01%)
Securities & Exchange Commission ("Commission") Establishes Clovis Oncology Fair Fund - Summary Notice of Distribution

/PRNewswire/ --

CLVS : 5.09 (+4.30%)
Clovis Oncology (CLVS) Shares Cross Above 200 DMA

In trading on Tuesday, shares of Clovis Oncology Inc crossed above their 200 day moving average of $5.89, changing hands as high as $5.92 per share. Clovis Oncology Inc shares are currently trading down...

CLVS : 5.09 (+4.30%)
Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027

PALM BEACH,  Fla., /PRNewswire/ -- Glioblastoma multiforme (GBM) is one of the areas where the research & development investments are high and where global studies are growing. Everyone is looking to...

CNSP : 1.7200 (unch)
AVXL : 21.36 (+2.89%)
BMY : 68.73 (+1.84%)
CLVS : 5.09 (+4.30%)
Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine

Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that Professor Dr. Richard P. Baum and Dr. Harshad R. Kulkarni, in conjunction with 3B Pharmaceuticals (Clovis' licensing partner and discoverer of...

CLVS : 5.09 (+4.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations....

See More

Key Turning Points

3rd Resistance Point 5.43
2nd Resistance Point 5.27
1st Resistance Point 5.18
Last Price 5.09
1st Support Level 4.92
2nd Support Level 4.76
3rd Support Level 4.67

See More

52-Week High 11.10
Fibonacci 61.8% 8.42
Fibonacci 50% 7.59
Fibonacci 38.2% 6.76
Last Price 5.09
52-Week Low 4.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar